#1 Weight Loss Doctor: The Truth About Obesity, Ozempic, Dieting, & How to Feel Better Now

Guest
Dr. Rocio Salas-Whalen
Read time
~5 min
Uploaded
17 Apr 2025
Duration
1:17:47
Views
510.5K
OPEN ON YOUTUBE ↗

KEYPOINTS

  • 01

    Obesity is a chronic, multifactorial disease, not a personal failing

    Dr. Rocio Salas-Whalen, triple board-certified in endocrinology, obesity medicine and internal medicine and the founder of New York Endocrinology, opens with an apology on behalf of doctors: 'We failed you.' She says obesity is not self-inflicted, and that weight loss should not be a full-time job that consumes your life. She has seen grown men cry in her office on hearing for the first time that it isn't their fault.

  • 02

    Five causes, and you control roughly one

    Her framework: lifestyle (diet, exercise, sitting); genetics, including research she cites suggesting parents' weight before conception affects their child; hormonal changes such as hypothyroidism, PCOS, perimenopause and menopause; aging, with muscle loss and more fat storage; and environment. Environment includes processed food, places where walking isn't practical, remote work, and endocrine-disrupting chemicals like BPA and pesticides that mimic hormones. Some antidepressants and blood-pressure drugs can also promote weight gain.

  • 03

    She says obesity raises cancer risk more than many people realize

    Salas-Whalen says obesity increases mortality and is the biggest risk factor for more than 15 cancers. She claims it's a bigger breast-cancer risk than alcohol, hormone therapy or genetics, and the top risk for pancreatic, colon, prostate and thyroid cancers. She argues it should be treated like type 2 diabetes or hypertension: lifestyle support plus medication, with lifestyle not replacing treatment.

  • 04

    GLP-1s are 20 years old and began with a lizard

    The first FDA-approved GLP-1, Byetta from Eli Lilly, arrived in 2005 as a twice-daily injection for type 2 diabetes. Salas-Whalen says Dr. John Eng, an endocrinologist researching at the Bronx VA, isolated the compound from Gila monster venom, which causes pancreatitis in its prey. Saxenda (daily) was approved for weight loss in 2012, Ozempic for diabetes in 2017, and the same drug was approved for weight loss in 2021 as Wegovy, partly for insurance reasons. She has prescribed GLP-1s for weight since 2010 and compares newer versions to iPhone upgrades.

  • 05

    They target both reasons we eat: fuel and reward

    GLP-1s suppress hunger hormones and raise satiety hormones, so people feel full on a third to a half of their usual portion; for many that means two small meals a day. They also act on receptors in the brain's reward area for food and alcohol, so an anticipated meal or drink no longer delivers the same pull. She says they only stimulate insulin when glucose is above normal, which is why they can be used without diabetes.

  • 06

    Thin doesn't mean healthy, so get a body-composition scan

    Salas-Whalen measures body composition at every visit, using bioimpedance (InBody) for accessibility, DEXA as an option, or MRI as the gold standard. She uses obesity thresholds of 32% body fat and up, against normal ranges of 18–28% for women and 10–20% for men. Some slim patients are 'skinny fat' (sarcopenic obesity), and people who think they need to lose 5–10 pounds may actually need to lose 20–25 because they're under-muscled.

  • 07

    Who is a candidate, and who isn't

    Her intake covers when a patient first became weight-conscious (often age nine or ten), medications, two generations of family weight history, and gynecological status. The only absolute contraindication she names is a personal or first-degree family history of medullary thyroid carcinoma; other thyroid cancers don't count. They're not recommended during pregnancy or breastfeeding.

  • 08

    Many people will need them long term, but not everyone

    Chronic diseases are controlled, not cured, she says, and stopping doesn't remove genetics, hormones, aging or environment. Lifelong obesity usually means long-term use. Someone who never struggled until gaining 30 pounds after pregnancy may not need it long term.

  • 09

    Muscle is the make-or-break factor

    Eating less can cost muscle indirectly, and she calls muscle your biggest metabolic organ, burning calories and pulling sugar from the blood when it contracts (Mel connects this to post-meal walks). She sees fat drop rapidly in patients who keep or gain muscle. Her targets: about 90–100 grams of protein a day and strength training twice a week, upper and lower body, with protein first. She attributes 'Ozempic face,' hair loss and loose skin to losing weight too fast without enough protein.

EXAMPLES

  • 01

    How weight loss was discovered by accident

    Early GLP-1s were hard sells: they were twice-daily injections with heavy nausea, and diabetes patients linked injections with insulin and 'failure.' Then patients came back to follow-ups with better glucose and lower weight. Salas-Whalen says that was unheard of, because most diabetes drugs, insulin included, promote weight gain.

  • 02

    The doctor's own six months on a GLP-1

    Salas-Whalen lifted weights from her early 20s and never struggled with weight. After having kids at 38 and 39 and entering perimenopause (her mother had early menopause), she couldn't lose 30 pounds. At 42 she used a GLP-1 for six months, returned to her weight and hasn't needed it since. She felt no shame and says it made her a more empathetic doctor. She tells new mothers to give themselves one to two years before worrying about weight.

  • 03

    'Three pounds, half of it muscle'

    Patients pleased with a three-pound loss often see on the scan that half was muscle. She says that's when they start lifting and eating more protein. Midway through treatment she sees a 'switch' from an external focus on looks to liking how strong they feel.

  • 04

    Mel's ad feed

    While researching the episode, Mel was flooded with ads for mail-order GLP-1s. She mentions friends who complained of indigestion and one warned about suicidal ideation. Salas-Whalen says she has never had to stop the drug for those symptoms and stresses that safety depends on the prescriber's expertise.

OTHER RELEVANT

  • 01

    Avoid med spas and compounded versions

    Medical offices don't sell FDA-approved GLP-1s in the office; they send prescriptions to a pharmacy. Compounded versions sold by med spas, telehealth or mail order are unregulated and may contain fillers. Salas-Whalen cites studies showing most hospital visits for severe side effects come from compounded drugs and overdosing, whereas FDA versions come in pre-dosed pens. 'Safety should not be jeopardized by cost.'

  • 02

    Skip microdosing

    She says sub-therapeutic doses lack evidence, rely on compounded products, and aren't needed if you're already metabolically healthy. She notes Eli Lilly's tirzepatide vial as one lower-dose option for maintenance.

  • 03

    Insist on real supervision

    Look for an obesity-medicine doctor, NP or PA, with follow-up every 8–10 weeks to adjust the dose and check muscle. Expect the conversation to take far longer than a 15-minute slot.